Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / PFM Health Sciences, LP
Form 13F · Q2 2026

PFM Health Sciences, LP

CIK 1442756Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.2B
Reported book value
98
Positions
12
Quarters on record
Top 50
Positions

PFM Health Sciences, LP — holdings

Top 50 positions of 98, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ASND Ascendis Pharma A/S233,171—$62M5.3%
2AXSM Axsome Therapeutics Inc.219,596−16.9%$54M4.6%
3LLY Eli Lilly & Co39,258−40.3%$47M4.0%
4JAZZ Jazz Pharmaceuticals Plc160,768−9.8%$39M3.3%
5HUM Humana Inc94,375—$37M3.2%
6UNH Unitedhealth Group Inc88,276+52.1%$37M3.1%
7NBIX Neurocrine Biosciences Inc213,407−1.1%$36M3.1%
8INBX Inhibrx Biosciences Inc308,385+1.0%$29M2.5%
9UTHR United Therapeutics Corp Del49,991+25.6%$27M2.3%
10RVMD Revolution Medicines Inc143,222+1.7%$27M2.3%
11ICLR Icon Pub Ltd Co136,482+137.4%$24M2.0%
12THC Tenet Healthcare Corp126,572−68.2%$24M2.0%
13EW Edwards Lifesciences Corp250,453−1.6%$23M1.9%
14WATERS CORP Waters Corp59,825+50.5%$22M1.9%
15PEN Penumbra Inc60,221−56.9%$19M1.6%
16BBIO Bridgebio Pharma Inc253,358−1.7%$19M1.6%
17SYK Stryker Corporation56,637+157.9%$18M1.5%
18MTD Mettler Toledo International13,344—$17M1.5%
19INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc401,208−30.2%$16M1.4%
20MRK Merck & Co Inc127,118—$16M1.4%
21CYTK Cytokinetics Inc191,686—$16M1.4%
22LNTH Lantheus Hldgs Inc146,403—$16M1.4%
23CNC Centene Corp Del248,867−5.5%$16M1.4%
24COOPER COS INC Cooper Cos Inc220,890+30.1%$16M1.4%
25MDGL Madrigal Pharmaceuticals Inc29,313−14.2%$16M1.4%
26ACHC Acadia Healthcare Company In524,934−9.9%$16M1.3%
27ORKA Oruka Therapeutics Inc158,825−8.7%$15M1.3%
28OSCR Oscar Health Inc519,016+3.8%$15M1.3%
29TMO Thermo Fisher Scientific Inc28,496+92.1%$14M1.2%
30CVS Cvs Health Corp137,457—$14M1.2%
31MERIT MED SYS INC Merit Med Sys Inc197,038+21.3%$14M1.2%
32PRAX Praxis Precision Medicines I38,575+8.9%$13M1.1%
33CLDX Celldex Therapeutics Inc New342,751+5.5%$13M1.1%
34NVO Novo-Nordisk A S265,016+34.4%$13M1.1%
35ITGR Integer Hldgs Corp126,669−6.2%$12M1.0%
36DNTH Dianthus Therapeutics Inc121,222−29.6%$12M1.0%
37DFTX Definium Therapeutics Inc249,020+21.3%$12M1.0%
38GILD Gilead Sciences Inc90,858—$11M1.0%
39RYTM Rhythm Pharmaceuticals Inc101,550−25.7%$11M1.0%
40HSIC Schein Henry Inc134,423−12.2%$11M1.0%
41ARWR Arrowhead Pharmaceuticals In131,667+104.8%$11M0.9%
42TNGX Tango Therapeutics Inc326,047−19.7%$10M0.9%
43TFX Teleflex Incorporated79,708—$10M0.9%
44VKTX Viking Therapeutics Inc255,330−3.0%$10M0.9%
45BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc141,914−24.2%$10M0.8%
46VERA Vera Therapeutics Inc224,289+28.3%$10M0.8%
47ROIV Roivant Sciences Ltd268,008+29.2%$9M0.8%
48CGON Cg Oncology Inc128,286−22.7%$9M0.8%
49AMRX Amneal Pharmaceuticals Inc480,715−48.3%$8M0.7%
50EPRX Eupraxia Pharmaceuticals Inc1.2M+123.8%$8M0.7%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.